Access to medicines and treatment: latest news

Access to medicines and treatment resources

Access to medicines and treatment features

Access to medicines and treatment news from aidsmap

More news

Access to medicines and treatment news selected from other sources

  • 7 Insurers Alleged To Have Discriminated Against HIV Patients

    The Affordable Care Act prohibits insurers from discriminating against people with serious illnesses, but some marketplace plans sidestep that taboo by making the drugs that people with HIV need unavailable or unaffordable, complaints filed recently with the Department of Health and Human Services' Office for Civil Rights allege.

    19 October 2016 | NPR
  • European delays on HIV prevention drug endanger gay men and others at risk of HIV

    A new report, PrEP Access in Europe, by the PrEP in Europe Initiative, a coalition of leading HIV organisations, calls on European governments and health authorities to make PrEP (pre-exposure prophylaxis) available to populations at imminent risk of HIV as a matter of urgency.

    18 October 2016 | NAT press release
  • People infected by hepatitis C in Canada have limited access to direct-acting antivirals

    A study conducted by researchers at the University of Montreal Hospital Research Centre (CRCHUM), The Kirby Institute at UNSW Australia, and the Canadian Network on Hepatitis C (CanHepC) shows that nearly everywhere in Canada, provinces and territories impose obstacles to the reimbursement of these medications by the public system because of their cost.

    17 October 2016 | CRCHUM Montreal
  • European regulator amends some Gilead hep C patent claims

    In a setback for Gilead Sciences, European regulators decided not to uphold all of its patent claims for the best-selling Sovaldi hepatitis C treatment, a move that could lead to generic versions of the medicine becoming available four years sooner than had been expected.

    06 October 2016 | STAT
  • The Medicines Patent Pool Announces MedsPaL: Its New Medicines Patents & Licences Database

    The Medicines Patent Pool today announced the launch of MedsPaL, its Medicines Patents & Licences Database, a new resource for information on the intellectual property status of priority medicines in developing countries.

    05 October 2016 | Medicines Patent Pool
  • UNITAID and FIND launch initiative to improve diagnostics and treatment for hepatitis C

    The US $38.3 million project will support the development of better, simpler, diagnostic tools for HCV where people seek care, and will introduce HCV testing and treatment over three and a half years in HIV programmes in seven countries: Cameroon, Georgia, India, Malaysia, Myanmar, Thailand and Vietnam.

    04 October 2016 | UNITAID
  • The key question on the Clinton Foundation is whether it saved lives. The answer is clearly yes.

    Does the Clinton Foundation do worthwhile charitable work? After reviewing foundation documents and talking to numerous people in the philanthropy and global health sectors familiar with its work, I’ve come to the conclusion that the Clinton Foundation is a real charitable enterprise that did enormous good. Its projects are of varying effectiveness, but its work is supported by credible, discriminating funders, and the foundation has least one huge accomplishment under its belt — an HIV/AIDS program that saved an untold number of lives.

    27 September 2016 | Vox
  • Behind Battle Over Drug Prices, Quiet Money From Big Pharma

    Is there a conflict of interest for hepatitis C advocates in accepting funds from pharmaceutical companies and representing the interests of patients when questions of drug pricing and access to treatment are being debated?

    19 September 2016 | Bloomberg
  • NHS funding cuts ‘forcing people to buy medicine through Facebook’

    Patients and researchers say the medicine is safe, however pharmacists have warned that medicine bought online could be placebo pills or contain dangerous ingredients.

    16 September 2016 | The Independent
  • Why 2.1 million Indians infected with HIV do not get the drugs they need

    Each of an estimated 2.1 million Indians infected with the human immunodeficiency virus (HIV) should be getting a cocktail of drugs to prolong their lives and reduce infections, but no more than 44% do, the minister of health told the Lok Sabha (parliament’s lower house) in April 2016.

    12 September 2016 | Firstpost
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap